The drug maker Pfizer announced that an early analysis of its coronavirus vaccine trial suggested the vaccine was robustly effective in preventing Covid-19. Pfizer, which developed the vaccine with the German drugmaker BioNTech, released only sparse details from its clinical trial, based on the first formal review of the data by an outside panel of experts.